Navigation Links
Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
Date:7/8/2008

NEW YORK, July 8 /PRNewswire/ -- Concentric Pharma Advertising, Inc., a five-year-old independent agency and one of the fastest growing in the field, has been selected by biopharmaceutical company Neuromed for U.S. professional communications supporting a developmental once-daily medication for the treatment of chronic pain.

The full-service assignment will include a broad range of activities, including branding, launch planning, marketing strategy, the creation of graphics and other support materials, and all tactical execution

Neuromed is a biopharmaceutical company focused on developing new and improved pain therapies. Concentric will work with the company on its most advanced program, the development of an extended-release formulation of a potent and widely used pain reliever that currently requires several doses daily for optimal effectiveness. Founded in Canada in 1998, Neuromed conducts its clinical and commercial operations from an office in the Philadelphia region. The company's research and financial operations are based in Vancouver, British Columbia.

"After an extensive review of 14 agencies, we selected Concentric for this assignment on the strength of its strategic and creative approach to the launch of our product," said Sean Cunliffe, Chief Commercial Officer of Neuromed.

Mario Orlando, vice president of marketing, will oversee the account from the client side. Tim Campbell, director of client services at Concentric, will manage the business on the agency side. Spending has not been disclosed.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing agency established in 2002, helps clients meet diverse business objectives through innovative thinking, elegant creative strategies, results-oriented tactics, and flawless execution.

The company is one of the fastest growing agencies in the healthcare field. In the past year alone, Concentric has tripled its
'/>"/>

SOURCE Concentric Pharma Advertising, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EH&E Launches Interactive Discussion Forum for Healthcare Environment of Care Professionals
2. IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year
3. First Complete Career Service for Life-Science Professionals
4. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
5. Online Career Site for Life Science Professionals Continues Growth
6. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
7. BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
10. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
11. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 China Cord Blood Corporation ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... a Hong Kong listed company ... into an agreement (the "Agreement") to purchase the Company,s ...
(Date:5/4/2015)... , May 4, 2015   Tocagen ... updated interim data from Tocagen,s ongoing investigational studies ... Symposium of the American Association of Neurological Surgeons ... held May 1-2, 2015, in Washington, ... company held a meeting with FDA and continues ...
(Date:5/4/2015)... 4, 2015   Sentrian ™, the Remote Patient ... with the Scripps Translational Science Institute (STSI) ... patients with chronic obstructive pulmonary disease (COPD), a chronic ... the nation,s third leading cause of death. The patients ... System , a wholly owned subsidiary of Anthem.   ...
(Date:5/1/2015)... Md. , May 1, 2015  Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... the $28.5 million second tranche of a $40 million ... Woodford first invested $25 million in NW ... Woodford entered into an agreement with the Company for ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 2China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... for the brand name Ranexa(R) (ranolazine)., On July ... granted,marketing authorization for ranolazine in all 27 European Union ... approval for the Ranexa brand name in Europe provides,important ...
... Named as CEO ... COO, ALTAMONTE SPRINGS, Fla., Aug. 14 Milestone ... and commercialization of niche oncology products, today,announced the appointment ... 12, 2008. Current President, CEO and Co-founder, Frank,Jacobucci, will ...
... Bio-,Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a ... raw materials,for use in pharmaceutical, nutraceutical and food ... for the three and six month periods,ended June ... 2008, sales of our products increased,substantially. Revenue received ...
Cached Biology Technology:CV Therapeutics Receives European Approval for the Brand Name Ranexa(R) 2Milestone Biosciences, LLC Further Strengthens Executive Management Team 2Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008 2
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has ... Market in Automotive Sector 2014-2018" report to their ... Recognition market in Automotive Sector to grow at a ... Gesture recognition is the ability of a device to ... Gesture recognition technology can be 2D-based or 3D-based. It ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... Dr. Sarit Larisch, Head of the Cell Death Research Laboratory ... awarded the prestigious Johnson & Johnson Focused Funding grant for ... Parkinson,s disease. The award, which is granted each year to ... announced in 2008, and officially conferred earlier this month at ...
... thousands of years it has been prescribed by traditional healers in ... pain to fever and flu. , Now for the first time, ... pain relieving properties of Hyptis crenata otherwise known ... mice, the team led by researcher Graciela Rocha was able to ...
... The atomic-level action of a remarkable class of ... the Lawrence Berkeley National Laboratory (Berkeley Lab) using a ... (ALS). These protein motors play pivotal roles in gene ... of all biological cells, as well as infectious agents, ...
Cached Biology News:Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4
Rabbit Anti-Ferret Whole Serum Antibody, Unconjugated...
... Molecular Imaging's proprietary Focus™ detector technology, while ... the R4. The microPET Focus 120 ... avaiable PET scanner. Focus scanners also ... scinitallor based PETsystems. The combination of ...
... pAcGHLT-A,B,C ... Vector Set,pAcGHLT-XylE ... Vector,Thrombin Powder,Thrombin ... Inhibitor Cocktail,Insect ...
... has been developed to significantly increase the ... Stability is increased at room temperature ... This product is subjected to 0.45 ... azide. This formulation insures consistently high ...
Biology Products: